Pharmaceutical manufacturer for Sumatriptan

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has Fifteen API and Six finished dosage facilities established across India & USA.

SMS Lifesciences India Limited, headquartered in Hyderabad, India, is a research-driven company with over three decades of experience. It is a public listed leading API manufacturer, supplying to major generic and innovator firms. With a focus on APIs, the company operates four state-of-the-art facilities and provides quality alternative manufacturing solutions to multinational companies for their contract research and manufacturing needs. The company has multiple manufacturing facilities supporting a wide range and capacity of APIs and Intermediates.

Dream that drives us at Nosch. The laudable goal that we aim for. The vision that suffuses us with the passion to innovate and excel. Over the past twenty one years, we have been ceaselessly engaged in a quest to sustain and improve the quality of life through creating safe pharmaceutical solutions. Our competencies have grown to embrace the entire pharmaceutical value chain-APIs and semi-finished Formulations. Today, with an impeccable reputation for uncompromising quality and timely delivery, Nosch has emerged as the partner of choice across the world.

Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has eight manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in New Drug Development, etc. Natco family currently consists of around 4500 employees, we are consistently ranked among fastest growing pharmaceutical companies in India. Natco is well recognized for its innovation in Pharmaceutical R&D.

Moehs Ibérica is the headquarters of the MOEHS Group. Moehs Ibérica currently has 138 employees in the following departments: Accounting/Treasury, Purchasing/Logistics, Sales/Marketing, Human Resources, IT, Quality Assurance/Regulatory Affairs, Research and Intellectual Property. It provides services to the entire group and each of its subsidiaries. In addition, it has its own R&D building with all its services and a plant dedicated to the production of small quantities of ingredients for the pharmaceutical industry, as well as a plant for the manufacture of High Potency Active Ingredients.

Founded in 1992 as an export-centric unit (EOU), Orchid Pharma Ltd. (Orchid) is an integrated company covering the entire pharmaceutical value chain from exploration to distribution with established expertise in research, production, and promotion. Presently, we are listed among the top 50 pharmaceutical firms in India and have a diverse presence in various therapeutic areas including anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals, and other oral and sterile products.

Hovione brings over six decades of experience as a CDMO and serves as a specialized integrated provider delivering solutions for drug substance, drug product intermediate, and drug product. With four FDA examined facilities in the United States, China, Ireland, and Portugal, as well as research laboratories in Portugal and the United States, the company supplies pharmaceutical customers with services for the development and compliant production of innovative drugs, including highly potent compounds. Hovione delivers a comprehensive range of development services and manufacturing capabilities in particle engineering such as Spray Drying.

SMS Lifesciences is a prominent participant in APIs/Intermediates production with a robust research and manufacturing team supported by cutting-edge facilities. Originating as a single-facility, single-product manufacturer in 1990, it has expanded into a multi-location group with products spanning various therapeutic segments. In 1997-98, SMS Group was accorded the export house status. Currently, SMS Lifesciences is a publicly listed company with a continuously expanding international and domestic customer base.

Srini Pharmaceuticals Pvt. Ltd., was established in 1995. USFDA, TGA and KFDA approved fully integrated global pharmaceutical company, located just about 60 KM's away from the Pharma Capital of India, Hyderabad. Our manufacturing facility has five fully equipped production blocks with most efficient functional utilities with multiple clean rooms having the ability to produce 10 API's at a time, supported by central quality control laborites with all sophisticated instruments by maintaining complete QMS. The state-of-the-Art Research and development laboratory recognized and approved by Department of Science and Technology, Government of India.

Smilax Laboratories Limited is a leading vertically integrated pharmaceutical organization, manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. The position today built by Smilax is due to its cutting edge research , world class manufacturing and a truly global supply chain management.

Established in the year 1991, SM Biomed Sdn. Bhd. is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and Intermediates based out in Malaysia With our state-of-the-art manufacturing facility certified by USFDA, EDQM, EUGMP and NPRA (Malaysia), we are dedicated to improve the quality of life through developing and delivering innovative solutions and products at an affordable cost. With a legacy spanning more than three decades and pioneers for Macrolide based antibiotics, we work with customers globally with speed, efficiency and cost effective manufacturing capabilities. SM Biomed has grown as a market leader in Macrolides antibiotics and evolved into a knowledge driven company providing reliable pharmaceutical services including developing and manufacturing APIs and Intermediates. From pipeline to production, we make innovative, quality driven and customised products more accessible. We are a quality driven and R&D focused API manufacturing company with a diverse product portfolio catering various therapeutic segments.

Maithili Life Sciences offers services including DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, and News related to GMP.

Vamsi Labs, founded in 1991, is a prominent Indian producer of active pharmaceutical ingredients (API). It specializes in anti-asthmatic, anti-migraine, and anti-psychotic APIs, serving both domestic and international markets with 50% sales contribution from the latter. Sales of anti-asthma products make up 60% of the total sales. Vamsi upholds stringent corporate governance, transparency, professionalism, and environmental conservation standards. The company is approved by USFDA and holds certifications for ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018. It also features a DSIR-certified R&D Lab, allowing Vamsi to continue innovating to meet the evolving requirements of the pharmaceutical industry. Vamsi is positioned for global expansion while maintaining its dedication to excellence and sustainability.

Established in 2001, Hunan Jiudian Pharmaceutical Co., Ltd. is a contemporary GMP pharmaceutical and publicly traded company specializing in finalized products, active pharmaceutical ingredients (APIs), excipients, traditional Chinese medicine, and nutritional supplements. Boasting 2 facilities, 400 researchers, and a total of 1,900 employees, the company's primary products are all independently researched by its own team, encompassing analgesic drugs, cardio-cerebrovascular treatments, anti-infection solutions, digestive and urinary system aids, as well as respiratory and anti-allergy products. Additionally, Hunan Jiudian Hongyang Pharmaceutical Co., Ltd. functions as a wholly-owned subsidiary of Jiudian, focusing on the production of APIs and excipients.

Therapiva is a prominent manufacturer of generic pharmaceuticals with a strong and innovative R&D center and a state-of-the-art API manufacturing plant. It offers a diverse product range spanning various medical areas and is capable of managing novel, intricate, and high-risk reactions. Therapiva provides new chemical entities (NCEs), cGMP intermediates, and key starting materials (KSMs) to global innovators. The company is furnished with adaptable, multi-faceted, and advanced infrastructure, customized to accommodate the production of complex molecular chemistry emerging from Innovator's development pipelines.

Established in 1999, Asymchem (PRC stock code:002821.SZ) is an international integrated Contract Development and Manufacturing Organization (CDMO) that offers drug R&D and production services for leading pharmaceutical and biotechnology firms. Their objective is to promote more intelligent, eco-friendly, and cost-efficient manufacturing processes to aid clinical research and commercialization efforts

Alter Pharma is a pharmaceutical group based in Anderlecht, Belgium, with offices in Ireland and the United States. With a workforce of more than 125 employees, the company distributes a diverse range of pharmaceutical products to pharmacies, wholesalers, hospitals, and retirement homes. Additionally, Alter Pharma is a major player in the global generics market, with approximately 15 months of presence.

LAXAI Life Sciences Pvt. Ltd. was founded in 2007, aiming to expedite the global pharmaceutical companies' discovery chemistry campaign by aiding the development of high-quality compounds at reduced costs and shorter timelines. A team of highly proficient research scientists brought LAXAI Life Sciences into existence, striving to deliver rapid and innovative solutions to worldwide pharmaceutical and biotechnological firms through integrated contract research services. The company combines Science, Innovation, and People to assist clients in enhancing their competitive edge.